US2016317631A1PendingUtilityA1

Increased t-cell tumor infiltration and eradication of metastases by mutant light

Assignee: UNIV CHICAGOPriority: Jun 11, 2003Filed: Jan 22, 2016Published: Nov 3, 2016
Est. expiryJun 11, 2023(expired)· nominal 20-yr term from priority
Inventors:Yang-Xin Fu
A61K 2039/53A61P 37/04C07K 2319/43C12N 2710/10043A61K 2039/5256C12N 2799/022A61P 35/04C12N 7/00A61K 40/428A61K 40/32A61K 40/11A61K 39/0011A61K 2239/38C07K 14/525A61K 2039/5152
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Mutant LIGHT expressed in a tumor environment elicited high levels of chemokines and adhesion molecules, accompanied by massive infiltration of naïve T lymphocytes. Methods and compositions to elicit immune responses against tumors including tumor volume reduction and eradication of metastasis using mutant LIGHT are disclosed.

Claims

exact text as granted — not AI-modified
1 .- 39 . (canceled) 
     
     
         40 . A method of inducing tumor-specific T-cell generation to reduce or control metastasis, the method comprising:
 (a) introducing a mutant LIGHT protein or a fragment thereof into an individual at a tumor site, wherein the mutant LIGHT protein or fragment does not have a proteolytic site; and   (b) reducing or controlling metastasis by inducing T-cell generation.   
     
     
         41 . The method of  claim 40 , wherein the generated T-cells are activated within a tumor site. 
     
     
         42 . The method of  claim 40 , wherein the generated T-cells circulate in blood. 
     
     
         43 . The method of  claim 42 , wherein the circulating T-cells are cancer specific. 
     
     
         44 . The method of  claim 40 , wherein the mutant LIGHT protein or the fragment is introduced into a tumor cell in vitro and the tumor cell expressing the mutant LIGHT protein or the fragment is delivered to the individual. 
     
     
         45 . The method of  claim 40 , wherein the T-cell generation is CD8+ dependent.

Join the waitlist — get patent alerts

Track US2016317631A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.